Mucosal Protection by Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibition

Cited by (369)

Items 101–200 of 369

  1. Coumarin Derivatives in Inflammatory Bowel Disease
    Luiz Cláudio Di Stasi · 2021 · Molecules
  2. Selective induction of integrin βi by hypoxia‐inducible factor: implications for wound healing
    Simon Keely, Louise Elaine Glover, Christopher F. MacManus, Eric L. Campbell, Melanie M. Scully, Glenn T. Furuta, Sean P. Colgan · 2008 · The FASEB Journal
  3. Targeting Hypoxia Signaling for Perioperative Organ Injury
    Xiaoyi Yuan, Jae W. Lee, Jessica L. Bowser, Viola Neudecker, Srikanth Sridhar, Holger K. Eltzschig · 2017 · Anesthesia & Analgesia
  4. Hypoxia. Regulation of NFκB signalling during inflammation: the role of hydroxylases
    Kathryn M. Oliver, Cormac T. Taylor, Eoin P. Cummins · 2009 · Arthritis Research & Therapy
  5. Activation of hypoxia-inducible factors ameliorates hypoxic distal tubular injury in the isolated perfused rat kidney
    Christian Rosenberger, Seymour Rosen, Ahuva Shina, Ulrich A. Frei, Kai‐Uwe Eckardt, Lee A. Flippin, Michael Arend, S J Klaus, Samuel Noam Heyman · 2008 · Nephrology Dialysis Transplantation
  6. Cucurbitacin I Induces Protective Autophagy in Glioblastoma in Vitro and in Vivo
    Yuan, Guang, Yan, Shao-Feng, Xue, Hao, Zhang, Ping, Sun, Jin-Tang, Li, Gang · 2014 · Journal of Biological Chemistry
  7. MicroRNA‐146a‐mediated downregulation of IRAK1 protects mouse and human small intestine against ischemia/reperfusion injury
    Cécilia Chassin, Cordelia Hempel, Silvia Stockinger, Aline Dupont, Joachim F. Kübler, Jochen Wedemeyer, Alain Vandewalle, Mathias Walter Hornef · 2012 · EMBO Molecular Medicine
  8. The role of hypoxia in intestinal inflammation
    Yatrik Madhukar Shah · 2016 · Molecular and Cellular Pediatrics
  9. Hypoxia and inflammatory bowel disease
    Eoin P. Cummins, Daniel Crean · 2016 · Microbes and Infection
  10. HIF-1α mediates the induction of IL-8 and VEGF expression on infection with Afa/Dr diffusely adheringE. coliand promotes EMT-like behaviour
    Gaëlle Cane, Amandine Ginouvès, Sandrine Marchetti, Roser Buscà, Jacques Pouysségur, Edurne Berra, Paul M Hofman, Valérie Vouret‐Craviari · 2009 · Cellular Microbiology
  11. Activation of hypoxia-inducible factor-1 protects airway epithelium against oxidant-induced barrier dysfunction
    Nels C. Olson, Milena Hristova, Nicholas H. Heintz, Karen M. Lounsbury, Albert van der Vliet · 2011 · American Journal of Physiology-Lung Cellular and Molecular Physiology
  12. A double‐edged sword: Role of butyrate in the oral cavity and the gut
    Xiaoyuan Guan, Wenjing Li, Huanxin Meng · 2020 · Molecular Oral Microbiology
  13. Biological functions of ecto-enzymes in regulating extracellular adenosine levels in neoplastic and inflammatory disease states
    Maria Serena Longhi, Simon Christopher Robson, Steven H. Bernstein, Sara Serra, Silvia Deaglio · 2013 · Journal of Molecular Medicine
  14. Pharmacological Characterization of 1-(5-Chloro-6-(trifluoromethoxy)-1H-benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic Acid (JNJ-42041935), a Potent and Selective Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor
    Barrett, Terrance D., Palomino, Heather L., Brondstetter, Theresa I., Kanelakis, Kimon C., Wu, Xiaodong, Haug, Peter V., Yan, Wen, Young, Andrew, Hua, Hong, Hart, Juliet C. et al. · 2011 · Molecular Pharmacology
  15. Macrophage polarization: an effective approach to targeted therapy of inflammatory bowel disease
    Yaoyao Du, Lan Rong, Yuanhua Cong, Lan Shen, Ning Zhang, Bing Wang · 2021 · Expert Opinion on Therapeutic Targets
  16. Therapeutic Manipulation of the HIF Hydroxylases
    Simon Nagel, Nick P. Talbot, Jasmin Mecinović, Thomas G. Smith, Alastair Mitchell Buchan, Christopher John Schofield · 2009 · Antioxidants and Redox Signaling
  17. Switching off CD73: a way to boost the activity of conventional and targeted antineoplastic therapies
    Luca Antonioli, Sergey V. Novitskiy, Kris F. Sachsenmeier, Matteo Fornai, Corrado Blandizzi, György Haskó · 2017 · Drug Discovery Today
  18. The role of mucosal barriers in human gut health
    Kangseok Seo, Jeong-Mi Seo, Jiyoun Yeun, Haebin Choi, Young‐In Kim, Sun-Young Chang · 2021 · Archives of Pharmacal Research
  19. Non-hypoxic Stabilization of Hypoxia-Inducible Factor Alpha (HIF-α): Relevance in Neural Progenitor/Stem Cells
    Javorina Milošević, Irena Adler, Anatol Manaenko, Sigrid C. Schwarz, Gail Walkinshaw, Michael Arend, Lee A. Flippin, Alexander Storch, Johannes Schwarz · 2009 · Neurotoxicity Research
  20. Hydroxylase Inhibition Abrogates TNF-α–Induced Intestinal Epithelial Damage by Hypoxia-Inducible Factor-1–Dependent Repression of FADD
    Hindryckx, Pieter, De Vos, Martine, Jacques, Peggy, Ferdinande, Liesbeth, Peeters, Harald, Olievier, Kim, Bogaert, Sara, Brinkman, Brigitta, Vandenabeele, Peter, Elewaut, Dirk et al. · 2010 · The Journal of Immunology
  21. Interplay of Hypoxia and A2B Adenosine Receptors in Tissue Protection
    Michael Koeppen, Tobias de la Garza Eckle, Holger K. Eltzschig · 2011 · Advances in pharmacology
  22. Hypoxia-inducible factor plays a gut-injurious role in intestinal ischemia reperfusion injury
    Kolenkode B. Kannan, Iriana Colorado, Diego C. Reino, David Palange, Qi Lu, Xiaofa Qin, Billy Abungu, Anthony C. Watkins, Francis J. Caputo, Da-Zhong Xu et al. · 2010 · American Journal of Physiology-Gastrointestinal and Liver Physiology
  23. Pharmacological intervention studies using mouse models of the inflammatory bowel diseases
    Iurii Koboziev, Fridrik J. Karlsson, Songlin Zhang, Matthew B. Grisham · 2011 · Inflammatory Bowel Diseases
  24. Hypoxia-Inducible Factor/MAZ-Dependent Induction of Caveolin-1 Regulates Colon Permeability through Suppression of Occludin, Leading to Hypoxia-Induced Inflammation
    Liwei Xie, Xiang Xue, Matthew J. Taylor, Sadeesh Kumar Ramakrishnan, Kenjiro Nagaoka, Cathy Hao, Frank J. Gonzalez, Yatrik Madhukar Shah · 2014 · Molecular and Cellular Biology
  25. Targeted delivery of the hydroxylase inhibitor DMOG provides enhanced efficacy with reduced systemic exposure in a murine model of colitis
    Murtaza M. Tambuwala, Mario C. Manresa, Eoin P. Cummins, Vincenzo Aversa, Ivan S. Coulter, Cormac T. Taylor · 2015 · Journal of Controlled Release
  26. Hypoxia-inducible factor 1 in autoimmune diseases
    Wei Deng, Xuebing Feng, Xia Li, Dandan Wang, Lingyun Sun · 2016 · Cellular Immunology
  27. HIF-1 in T cells ameliorated dextran sodium sulfate-induced murine colitis
    Higashiyama, Masaaki, Hokari, Ryota, Hozumi, Hideaki, Kurihara, Chie, Ueda, Toshihide, Watanabe, Chikako, Tomita, Kengo, Nakamura, Mitsuyasu, Komoto, Shunsuke, Okada, Yoshikiyo et al. · 2012 · Journal of Leukocyte Biology
  28. Inhibition of Prolyl Hydroxylase Domain-Containing Protein Suppressed Lipopolysaccharide-Induced TNF-α Expression
    Kotaro Takeda, Toshihiro Ichiki, Eriko Narabayashi, Keita Inanaga, Ryohei Miyazaki, Toru Hashimoto, Hirohide Matsuura, Jiro Ikeda, Toshio Miyata, Kenji Sunagawa · 2009 · Arteriosclerosis Thrombosis and Vascular Biology
  29. Recent Advances in Developing Inhibitors for Hypoxia-Inducible Factor Prolyl Hydroxylases and Their Therapeutic Implications
    So Yeon Kim, Eun Yang · 2015 · Molecules
  30. Elongation Factor 2 Kinase Is Regulated by Proline Hydroxylation and Protects Cells during Hypoxia
    Claire E. Moore, Halina Mikolajek, Sergio Regufe da Mota, Wang Xuemin, Justin W. Kenney, Jörn M. Werner, Christopher G. Proud · 2015 · Molecular and Cellular Biology
  31. Results of the 2nd Scientific Workshop of the ECCO (III): Basic mechanisms of intestinal healing
    Florian Rieder, Thomas Karrasch, Shomron Ben‐Horin, Anja Schirbel, Robert Ehehalt, Jan Wehkamp, Colin G. de Haar, Dominique Velin, Giovanni Latella, Franco Scaldaferri et al. · 2011 · Journal of Crohn s and Colitis
  32. PHD3 Stabilizes the Tight Junction Protein Occludin and Protects Intestinal Epithelial Barrier Function
    Ying Chen, Hai-Sheng Zhang, Guo‐Hua Fong, Qiulei Xi, Guohao Wu, Chenguang Bai, Zhi‐Qiang Ling, Fan Li, Yiming Xu, Yan-qing Qin et al. · 2015 · Journal of Biological Chemistry
  33. Mononuclear phagocytes orchestrate prolyl hydroxylase inhibition-mediated renoprotection in chronic tubulointerstitial nephritis
    Gunnar Schley, Bernd Klanke, Joanna Maria Kalucka, Valentin Schatz, Christoph Daniel, Marleen Mayer, Margarete Goppelt‐Struebe, Martin Herrmann i, Margrét Þorsteinsdóttir, Runólfur Pálsson et al. · 2019 · Kidney International
  34. Hypoxic Environment Promotes Barrier Formation in Human Intestinal Epithelial Cells through Regulation of MicroRNA 320a Expression
    Stephanie Muenchau, Rosalie Deutsch, Inês J. de Castro, Thomas Hielscher, Nora Heber, Beate Niesler, Marina Lušić, Megan Lynn Stanifer, Steeve Boulant · 2019 · Molecular and Cellular Biology
  35. Hypoxia-sensitive pathways in inflammation-driven fibrosis
    Mario C. Manresa, Catherine Godson, Cormac T. Taylor · 2014 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
  36. The Hypoxia–Adenosine Link during Intestinal Inflammation
    Jessica L. Bowser, Luan Hai Phan, Holger K. Eltzschig · 2018 · The Journal of Immunology
  37. HIF-1α is required for hematopoietic stem cell mobilization and 4-prolyl hydroxylase inhibitors enhance mobilization by stabilizing HIF-1α
    Catherine E. Forristal, Bianca Nowlan, Rebecca N. Jacobsen, Valérie Barbier, Gail Walkinshaw, Carl R. Walkley, Ingrid G. Winkler, Jean-Pierre Lévesque · 2015 · Leukemia
  38. Hypoxia-Inducible Factor Activation Protects the Kidney from Gentamicin-Induced Acute Injury
    Jeong-myung Ahn, Sun Jin You, Yun Mi Lee, Se Won Oh, Shin Young Ahn, Sejoong Kim, Ho Jun Chin, Dong‐Wan Chae, Ki Young Na · 2012 · PLoS ONE
  39. New Insights into Protein Hydroxylation and Its Important Role in Human Diseases
    Giada Zurlo, Jianping Guo, Mamoru Takada, Wenyi Wei, Qing Hua Zhang · 2016 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  40. Hypoxia signaling during intestinal ischemia and inflammation
    Almut Grenz, Eric T. Clambey, Holger K. Eltzschig · 2012 · Current Opinion in Critical Care
  41. Exploring the HIFs, buts and maybes of hypoxia signalling in disease: lessons from zebrafish models
    Philip M. Elks, Stephen A. Renshaw, Annemarie H. Meijer, Sarah R. Walmsley, Fredericus J. van Eeden · 2015 · Disease Models & Mechanisms
  42. Cyclooxygenase-2 and Hypoxia-Inducible Factor-1α protein expression is related to inflammation, and up-regulated since the early steps of colorectal carcinogenesis
    Francesco Mariani, Paola Sena, Laura Marzona, Massimo Riccio, Rita Adriana Fano, Paola Manni, Carmela Di Gregorio, Annalisa Pezzi, Maurizio Ponz de Leòn, Sebastiano Monni et al. · 2009 · Cancer Letters
  43. Reducing radiation-induced gastrointestinal toxicity — the role of the PHD/HIF axis
    Monica M. Olcina, Amato J. Giaccia · 2016 · Journal of Clinical Investigation
  44. Hypoxia-inducible factor-2α plays a role in mediating oesophagitis in GORD
    Xiaofang Huo, Agoston T. Agoston, Kerry B. Dunbar, Daisha Jane Cipher, Xi Zhang, Chunhua Yu, Edaire Cheng, Qiuyang Zhang, Thai H. Pham, Uttam K. Tambar et al. · 2016 · Gut
  45. Transmembrane prolyl 4-hydroxylase is a fourth prolyl 4-hydroxylase regulating EPO production and erythropoiesis
    Laitala, Anu, Aro, Ellinoora, Walkinshaw, Gail, Mäki, Joni M., Rossi, Maarit, Heikkilä, Minna, Savolainen, Eeva-Riitta, Arend, Michael, Kivirikko, Kari I., Koivunen, Peppi et al. · 2012 · Blood
  46. Oral Delivery of Prolyl Hydroxylase Inhibitor
    Ellen Marks, Bridie J. Goggins, Jocelle Cardona, Siobhan Cole, Kyra Minahan, Sean W. Mateer, Marjorie M. Walker, Robert A. Shalwitz, Simon Keely · 2015 · Inflammatory Bowel Diseases
  47. Local Stabilization of Hypoxia-Inducible Factor-1α Controls Intestinal Inflammation via Enhanced Gut Barrier Function and Immune Regulation
    Young‐In Kim, Eun-Je Yi, Young‐Dae Kim, A Reum Lee, Jiwoung Chung, Hae Chan Ha, Joong Myung Cho, Seong-Ryeol Kim, Hyun‐Jeong Ko, Jae Hee Cheon et al. · 2021 · Frontiers in Immunology
  48. A possible role for hypoxia-induced apelin expression in enteric cell proliferation
    Song Han, Guiyun Wang, Qi Xiang, Heung M. Lee, Ella W. Englander, George H. Greeley · 2008 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
  49. Proresolution effects of hydrogen sulfide during colitis are mediated through hypoxia‐inducible factor‐1α
    Kyle L. Flannigan, Terence A. Agbor, Jean‐Paul Motta, José G. Ferraz, Rui Wang, André G. Buret, John Lawrence Wallace · 2014 · The FASEB Journal
  50. An Endogenously Anti-Inflammatory Role for Methylation in Mucosal Inflammation Identified through Metabolite Profiling
    Douglas J. Kominsky, Simon Keely, Christopher F. MacManus, Louise Elaine Glover, Melanie M. Scully, Colm B. Collins, Brittelle Bowers, Eric L. Campbell, Sean P. Colgan · 2011 · The Journal of Immunology
  51. Nix-Mediated Mitophagy Modulates Mitochondrial Damage During Intestinal Inflammation
    Garret Vincent, Elizabeth A. Novak, Vei Shaun Siow, Kellie E. Cunningham, Brian D. Griffith, Thomas E. Comerford, Heather L. Mentrup, Donna Beer Stolz, Patricia Loughran, Sarangarajan Ranganathan et al. · 2020 · Antioxidants and Redox Signaling
  52. Targeting the A2B adenosine receptor during gastrointestinal ischemia and inflammation
    Holger K. Eltzschig, Jesús Rivera–Nieves, Sean P. Colgan · 2009 · Expert Opinion on Therapeutic Targets
  53. Metabolic Host–Microbiota Interactions in Autophagy and the Pathogenesis of Inflammatory Bowel Disease (IBD)
    Alexander S. Dowdell, Sean P. Colgan · 2021 · Pharmaceuticals
  54. The Therapeutic Effect of Chelidonic Acid on Ulcerative Colitis
    Dae‐Seung Kim, Su Jin Kim, Min-Cheol Kim, Yong‐Deok Jeon, Jae‐Young Um, Seung‐Heon Hong · 2012 · Biological and Pharmaceutical Bulletin
  55. Hypoxia and Integrin-Mediated Epithelial Restitution during Mucosal Inflammation
    Bridie J. Goggins, Ciaran Chaney, Graham L Radford‐Smith, Jay Christopher Horvat, Simon Keely · 2013 · Frontiers in Immunology
  56. The hypoxia–inflammation link and potential drug targets
    Michael Koeppen, Tobias de la Garza Eckle, Holger K. Eltzschig · 2011 · Current Opinion in Anaesthesiology
  57. Ex Vivo Intestinal Sacs to Assess Mucosal Permeability in Models of Gastrointestinal Disease
    Sean W. Mateer, Jocelle Cardona, Ellen Marks, Bridie J. Goggin, Susan Hua, Simon Keely · 2016 · Journal of Visualized Experiments
  58. Signaling hypoxia by hypoxia-inducible factor protein hydroxylases: a historical overview and future perspectives
    Peter Peter Ratcliffe, Tammie Bishop · 2014 · Hypoxia
  59. Neutrophil priming by hypoxic preconditioning protects against epithelial barrier damage and enteric bacterial translocation in intestinal ischemia/reperfusion
    Yen‐Zhen Lu, Chi-Chin Wu, Yi-Chen Huang, Ching-Ying Huang, Chung-Yi Yang, Tsung‐Chun Lee, Chau-Fong Chen, Linda Chia‐Hui Yu · 2012 · Laboratory Investigation
  60. The Inflammatory Tissue Microenvironment in IBD
    Sean P. Colgan, Valerie F. Curtis, Eric L. Campbell · 2013 · Inflammatory Bowel Diseases
  61. Anti‐inflammatory actions of adrenomedullin through fine tuning of HIF stabilization
    Christopher F. MacManus, Eric L. Campbell, Simon Keely, Adrianne Burgess, Douglas J. Kominsky, Sean P. Colgan · 2011 · The FASEB Journal
  62. Betulinic acid hydroxamate prevents colonic inflammation and fibrosis in murine models of inflammatory bowel disease
    María E. Prados, Adela García‐Martín, Juan Diego Unciti-Broceta, Belén Palomares, Juan Antonio Collado, Alberto Minassi, Marco A. Calzado, Giovanni Appendino, Eduardo Muñóz · 2020 · Acta Pharmacologica Sinica
  63. Metabolic regulation of intestinal epithelial barrier during inflammation
    Sean P. Colgan, Valerie F. Curtis, Jordi M. Lanis, Louise Elaine Glover · 2014 · Tissue Barriers
  64. Targeting Hypoxia-Inducible Factor-1 (HIF-1) Signaling in Therapeutics: Implications for the Treatment of Inflammatory Bowel Disease
    Simon Andrew Hirota, Paul L. Beck, Justin A. MacDonald · 2009 · Recent Patents on Inflammation & Allergy Drug Discovery
  65. Neutrophils and inflammatory resolution in the mucosa
    Sean P. Colgan · 2015 · Seminars in Immunology
  66. Yak milk–derived exosomal microRNAs regulate intestinal epithelial cells on proliferation in hypoxic environment
    Hang Gao, Fazheng Ren, Pengcheng Wen, L.X. Xie, Rui Wang, Z.N. Yang, Y.X. Li · 2020 · Journal of Dairy Science
  67. Hypoxia and hypoxia-inducible factors in myeloid cell-driven host defense and tissue homeostasis
    Jantsch, Jonathan, Schödel, Johannes · 2015 · Immunobiology
  68. Hydroxylase-dependent regulation of the NF-κB pathway
    Carsten C. Scholz, Cormac T. Taylor · 2013 · Biological Chemistry
  69. Hypoxia-adaptive pathways: A pharmacological target in fibrotic disease?
    Moritz J. Strowitzki, Alina S. Ritter, Gwendolyn Kimmer, Martin A. Schneider · 2019 · Pharmacological Research
  70. Hydroxylases as therapeutic targets in inflammatory bowel disease
    Eoin P. Cummins, Glen A. Doherty, Cormac T. Taylor · 2013 · Laboratory Investigation
  71. Molecular Mechanisms of Action and Therapeutic Uses of Pharmacological Inhibitors of HIF–Prolyl 4-Hydroxylases for Treatment of Ischemic Diseases
    Vaithinathan Selvaraju, Narasimham L. Parinandi, Ram Sudheer Adluri, Joshua W. Goldman, Naveed Hussain, Juan A. Sánchez, Nilanjana Maulik · 2013 · Antioxidants and Redox Signaling
  72. Activation of HIF-1α does not increase intestinal tumorigenesis
    Xiang Xue, Sadeesh Kumar Ramakrishnan, Yatrik Madhukar Shah · 2014 · American Journal of Physiology-Gastrointestinal and Liver Physiology
  73. Regulation of IL-12p40 by HIF controls Th1/Th17 responses to prevent mucosal inflammation
    Ellen Marks, Crystal R. Naudin, Garry P. Nolan, Bridie J. Goggins, Grace L. Burns, Sean W. Mateer, J.K. Latimore, Kyra Minahan, Maximilian W. Plank, Paul S. Foster et al. · 2017 · Mucosal Immunology
  74. Neutrophils as Components of Mucosal Homeostasis
    Caroline H. T. Hall, Eric L. Campbell, Sean P. Colgan · 2017 · Cellular and Molecular Gastroenterology and Hepatology
  75. Loss of PHLPP protects against colitis by inhibiting intestinal epithelial cell apoptosis
    Yang‐An Wen, Xin Li, Tatiana Goretsky, Heidi L. Weiss, Terrence A. Barrett, Tianyan Gao · 2015 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  76. Hypoxia-inducible factor as a bridge between healthy barrier function, wound healing, and fibrosis
    Calen A. Steiner, Ian M. Cartwright, Cormac T. Taylor, Sean P. Colgan · 2022 · American Journal of Physiology-Cell Physiology
  77. Involvement of HIF-1α in MLCK-dependent Endothelial Barrier Dysfunction in Hypoxia
    Huabing Qi, Pei Wang, Chen Liu, Mu Li, Shiliang Wang, Yuesheng Huang, Fengjun Wang · 2011 · Cellular Physiology and Biochemistry
  78. Anti-Inflammatory Effects of Hyperbaric Oxygenation during DSS-Induced Colitis in BALB/c Mice Include Changes in Gene Expression ofHIF-1α, Proinflammatory Cytokines, and Antioxidative Enzymes
    Sanja Novak, Ines Drenjančević, Rosemary Vuković, Zoltán Kellermayer, Anita Ćosić, Maja Tolušić Levak, Péter Balogh, Filip Čulo, Martina Mihalj · 2016 · Mediators of Inflammation
  79. In Vivo and In Vitro Evidence of the Involvement of CXCL1, a Keratinocyte-Derived Chemokine, in Equine Laminitis
    Rafael Resende Faleiros, Britta Sigrid Leise, Trina L. Westerman, Cailing Yin, Gerard James Nuovo, James K. Belknap · 2009 · Journal of Veterinary Internal Medicine
  80. Targeting the Hypoxia-Sensing Pathway in Clinical Hematology
    Catherine E. Forristal, Jean-Pierre Lévesque · 2013 · Stem Cells Translational Medicine
  81. Hypoxia‐sensitive pathways in intestinal inflammation
    Eric Brown, Cormac T. Taylor · 2017 · The Journal of Physiology
  82. Protective effect of decursin and decursinol angelate-rich Angelica gigas Nakai extract on dextran sulfate sodium-induced murine ulcerative colitis
    Sarang Oh, Seon Ok, Tae-Sung Jung, Sang-Ok Jeon, Ji-Min Park, Ji-Wook Jung, Deok‐Seon Ryu · 2017 · Asian Pacific Journal of Tropical Medicine
  83. Hypoxia-inducible factor-1α: a promising therapeutic target for autoimmune diseases
    Shi‐Yang Guan, Rui‐Xue Leng, Jin-Hui Tao, Xiang-Pei Li, Dong‐Qing Ye, Nancy J. Olsen, Song Guo Zheng, Hai‐Feng Pan · 2017 · Expert Opinion on Therapeutic Targets
  84. MiR-155 contributes to intestinal barrier dysfunction in DSS-induced mice colitis via targeting HIF-1α/TFF-3 axis
    Yujin Liu, Feng Zhu, Huarong Li, Heng Fan, Hui Wu, Yalan Dong, Si Chu, Chen Tan, Quansheng Wang, Hongxia He et al. · 2020 · Aging
  85. In vivo functions of the prolyl‐4‐hydroxylase domain oxygen sensors: direct route to the treatment of anaemia and the protection of ischaemic tissues
    Dörthe Magdalena Katschinski · 2008 · Acta Physiologica
  86. Non-canonical HIF-1 stabilization contributes to intestinal tumorigenesis
    Nadine Rohwer, Sandra Jumpertz, Merve Erdem, Antje Egners, Klaudia Theresa Warzecha, Athanassios Fragoulis, Anja Andrea Kühl, Rafael Kramann, Sabine Neuß, Ines Rudolph et al. · 2019 · Oncogene
  87. Haematopoietic prolyl hydroxylase‐1 deficiency promotes M2 macrophage polarization and is both necessary and sufficient to protect against experimental colitis
    Sophie Van Welden, Martine De Vos, Ben Wielockx, Simon Jan Tavernier, Mélissa Dullaers, Sara Neyt, Benedicte Descamps, Lindsey Devisscher, Sarah Devriese, Lien Van den Bossche et al. · 2016 · The Journal of Pathology
  88. Dynamics of Prolyl Hydroxylases Levels During Disease Progression in Experimental Colitis
    Hamid A. Bakshi, Vijay Kumar Mishra, Saurabh Satija, Meenu Mehta, Faruk L. Hakkim, Prashant Kesharwani, Kamal Dua, Dinesh Kumar Chellappan, Nitin B. Charbe, Garima Shrivastava et al. · 2019 · Inflammation
  89. Blockade of hypoxia-inducible factor-1α by YC-1 attenuates interferon-γ and tumor necrosis factor-α-induced intestinal epithelial barrier dysfunction
    Hang Liu, Mu Li, Pei Wang, Fengjun Wang · 2011 · Cytokine
  90. 1,2,4-Triazolo-[1,5-a]pyridine HIF Prolylhydroxylase Domain-1 (PHD-1) Inhibitors With a Novel Monodentate Binding Interaction
    Saleh Ahmed, Andrew Ayscough, Greg R. Barker, Hannah E. Canning, Richard Davenport, Robert Downham, David Harrison, Kerry Jenkins, Natasha Kinsella, David G. Livermore et al. · 2017 · Journal of Medicinal Chemistry
  91. Immunologic Consequences of Hypoxia during Critical Illness
    Harmke D. Kiers, Gert‐Jan Scheffer, Johannes G. van der Hoeven, Holger K. Eltzschig, Peter Pickkers, Matthijs Kox · 2016 · Anesthesiology
  92. Oxygen sensing in intestinal mucosal inflammation
    Katharina Flück, Joachim Fandrey · 2015 · Pflügers Archiv - European Journal of Physiology
  93. Pharmacologic stabilization of hypoxia-inducible transcription factors protects developing mouse brain from hypoxia-induced apoptotic cell death
    Regina Trollmann, Melvyn Richter, Susan Jung, Gail Walkinshaw, Florian A. Brackmann · 2014 · Neuroscience
  94. On the role of ischemia in the pathogenesis of IBD
    Christopher B. Ibrahim, Olga C. Aroniadis, Lawrence J. Brandt · 2009 · Inflammatory Bowel Diseases
  95. Hypoxia-inducible factor prolyl-4-hydroxylase-1 is a convergent point in the reciprocal negative regulation of NF-κB and p53 signaling pathways
    Karim Ullah, Ann-Helen Rosendahl, Valerio Izzi, Ulrich Bergmann, Taina A. Pihlajaniemi, Joni M. Mäki, Johanna Myllyharju · 2017 · Scientific Reports
  96. Mitochondrial dysfunctions in T cells: focus on inflammatory bowel disease
    Hoyul Lee, Jae‐Han Jeon, Eun Soo Kim · 2023 · Frontiers in Immunology
  97. Randomised clinical trial: a phase 1b study of GB004, an oral HIF‐1α stabiliser, for treatment of ulcerative colitis
    Silvio Danese, Barrett G. Levesque, Brian G. Feagan, Alina Jucov, Bal Raj Bhandari, Rish K. Pai, Kristen Taylor Meadows, Brian J. Kirby, Jean‐Marie Bruey, Allan David Olson et al. · 2022 · Alimentary Pharmacology & Therapeutics
  98. Therapeutic Effects and Molecular Mechanism of Chlorogenic Acid on Polycystic Ovarian Syndrome: Role of HIF-1alpha
    Zhenghong Zhang, Congjian Shi, Zhengchao Wang · 2023 · Nutrients
  99. Joint Involvement Associated with Inflammatory Bowel Disease
    Martine De Vos · 2009 · Digestive Diseases
  100. Hypoxia-Induced Signaling in Gut and Liver Pathobiology
    Sumeet A. Solanki, Yatrik Madhukar Shah · 2023 · Annual Review of Pathology Mechanisms of Disease